A 55-year-old man presented to the author\'s department with a 1-day history of abdominal pain and bloody diarrhea. Four months previously, chronic gastritis due to *Helicobacter pylori* was diagnosed at a medical check-up. After failure of eradication by rabeprazole-amoxicillin-clarithromycin triple therapy (first-line therapy), he was started on rabeprazole-amoxicillin-metronidazole triple therapy (second-line therapy) 5 days earlier. Vital signs were normal, and his abdomen was soft. Although laboratory evaluation showed a normal leukocyte count and a C-reactive protein of 0.5 mg/dL (range \<0.3), computed tomography revealed thickening of the intestinal wall from the transverse colon to splenic flexure ([Fig. 1](#F1){ref-type="fig"}). Colonoscopy confirmed hemorrhagic and edematous mucosa ([Fig. 2](#F2){ref-type="fig"}). A histological evaluation of specimens obtained by biopsy showed no specific findings. Antibiotic-associated hemorrhagic colitis (AAHC) was diagnosed by a positive stool culture for *Klebsiella oxytoca* as well as the abovementioned findings; thus, eradication therapy was discontinued. His symptoms resolved within 2 days.

AAHC is a rare but important complication of antibiotic therapy. The etiology remains unclear; however, several mechanisms, including allergic reaction, mucosal ischemia, and microbial substitution by antibiotic-induced overgrowth of *K. oxytoca*, have been proposed.[@B1] Symptoms include diarrhea, abdominal tenderness, and ultimately bloody diarrhea occurring within 1 week of antibiotic use; furthermore, symptoms typically disappear within 3 days after cessation of antibiotic therapy.[@B2] Since AAHC is mainly present in the right or transverse colon, sigmoidoscopy alone would miss many cases.[@B1]

*H. pylori* infection is associated with peptic ulcers and gastric cancer. The International Agency for Research on Cancer recommends population screening for *H. pylori* and its eradication to reduce the incidence of gastric cancer.[@B3] Additionally, the incidence rate of AAHC induced by *H. pylori* eradication therapy was reported to be \<1% \[first-line therapy 0.35--0.6% vs. second-line therapy 0.96%\] in Japan.[@B4]

In the present case, the important clinical messages are as follows:

\(1\) Physicians should be cautious of AAHC in patients taking antibiotics.

\(2\) Despite no adverse events associated with first-line therapy for *H. pylori* eradication, second-line therapy can cause AAHC.

\(3\) Colonoscopy is required for the diagnosis of AAHC.
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